share_log

Pfizer | 4: Statement of changes in beneficial ownership of securities-Director Gottlieb Scott

Pfizer | 4: Statement of changes in beneficial ownership of securities-Director Gottlieb Scott

輝瑞 | 4:持股變動聲明-董事 Gottlieb Scott
美股SEC公告 ·  11/01 04:11

牛牛AI助理已提取核心訊息

On October 30, 2024, Scott Gottlieb, reported a completed transaction of purchasing 1,000 shares of Pfizer Inc (PFE) common stock at a price of $28.24 per share. Following this transaction, Gottlieb's direct holdings in the company increased to a total of 10,000 shares. The transaction, described as an open market or private purchase, reflects a significant investment in Pfizer by Gottlieb, with the total value of the acquired shares amounting to $28,240.
On October 30, 2024, Scott Gottlieb, reported a completed transaction of purchasing 1,000 shares of Pfizer Inc (PFE) common stock at a price of $28.24 per share. Following this transaction, Gottlieb's direct holdings in the company increased to a total of 10,000 shares. The transaction, described as an open market or private purchase, reflects a significant investment in Pfizer by Gottlieb, with the total value of the acquired shares amounting to $28,240.
2024年10月30日,Scott Gottlieb 報告完成了購買1000股輝瑞公司(PFE)普通股的交易,每股價格爲28.24美元。在這筆交易之後,Gottlieb在該公司的直接持股增加到總共10000股。這筆交易被描述爲公開市場或私人購買,反映了Gottlieb對輝瑞的重大投資,所獲得股份的總價值爲28240美元。
2024年10月30日,Scott Gottlieb 報告完成了購買1000股輝瑞公司(PFE)普通股的交易,每股價格爲28.24美元。在這筆交易之後,Gottlieb在該公司的直接持股增加到總共10000股。這筆交易被描述爲公開市場或私人購買,反映了Gottlieb對輝瑞的重大投資,所獲得股份的總價值爲28240美元。

譯文內容由第三人軟體翻譯。


牛牛AI助手部分由第三方人工智慧模型基於資訊內容自動產生。


以上內容僅用作資訊或教育之目的,不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。